Skip to main content
NCBI home page
Springer logoLink to Springer
. 2015 Nov 20;77:439. doi: 10.1007/s00280-015-2890-9

Erratum to: Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer

Johanna C Bendell 1,✉, Lee S Rosen 2, Robert J Mayer 3, Jonathan W Goldman 2, Jeffrey R Infante 1, Fabio Benedetti 4, Donghu Lin 5, Hirokazu Mizuguchi 4, Christopher Zergebel 4, Manish R Patel 6
PMCID: PMC4969883  PMID: 26589791

Erratum to: Cancer Chemother Pharmacol (2015) 76:925–932 DOI 10.1007/s00280-015-2850-4

The original version of this article unfortunately contained a mistake. The affiliations of Lee S. Rosen, Jonathan W. Goldman, Hirokazu Mizuguchi, Fabio Benedetti, and Christopher Zergebel are incorrect. The correct affiliations should be:

Lee S. Rosen and Jonathan W. Goldman

University of California, 2020 Santa Monica Blvd., Suite 600, Santa Monica, CA 90404, USA

Hirokazu Mizuguchi, Fabio Benedetti, and Christopher Zergebel

Taiho Oncology Inc., 202 Carnegie Center, Suite 100, Princeton, NJ 08540, USA

Footnotes

The online version of the original article can be found under doi:10.1007/s00280-015-2850-4.

Articles from Cancer Chemotherapy and Pharmacology are provided here courtesy of Springer

RESOURCES